DNAiTECH is pioneering the development of PLACID, a new approach for point-of-care molecular testing that will bring disease detection...

CRISPR-based detection of LAMP reactions provides three significant advantages. The first is that using CRISPR as the biochemical readout...

The World Health Organisation describes neglected tropical diseases (NTDs) as a diverse group of 20 conditions mainly prevalent in...

Are you interested in rapid, sensitive, and accurate diagnostics with the potential to meet point-of-care (POC) testing requirements? The...